Indication
Muscarine toxicity
Muscarine toxicity is a peripheral cholinergic toxidrome primarily caused by the ingestion of toxic mushrooms, particularly from the *Inocybe* and *Clitocybe* genera, or from exposure to muscarinic receptor agonists. Read more about Muscarine toxicity
24 drugs 24 manufacturers
Drugs that treat it
Common Muscarine toxicity therapies.
ATROPINE SULFATE (atropine sulfate in 0.9 % sodium chloride)
ATROPINE SULFATE
ATROPINE SULFATE
ATROPINE SULFATE
ATROPINE SULFATE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonMuscarine toxicity is a peripheral cholinergic toxidrome primarily caused by the ingestion of toxic mushrooms, particularly from the *Inocybe* and *Clitocybe* genera, or from exposure to muscarinic receptor agonists.
Pathophysiologically, the alkaloid muscarine acts as an agonist on postganglionic parasympathetic muscarinic acetylcholine receptors, stimulating the autonomic and peripheral nervous systems without significantly crossing the blood-brain barrier.
Clinical manifestations typically appear rapidly, often within thirty minutes to two hours after exposure, and are characterized by excessive exocrine secretions and autonomic hyperstimulation.
Defining features include pronounced diaphoresis, salivation, lacrimation, miosis, bronchospasm, bronchorrhea, bradycardia, abdominal cramping, nausea, vomiting, and diarrhea.
- nih.gov
Muscarine toxicity is a peripheral cholinergic toxidrome primarily caused by the ingestion of toxic mushrooms, particularly from the *Inocybe* and *Clitocybe* genera, or from exposure to muscarinic receptor agonists Clinical manifestations typically appear rapidly, often within thirty minutes to two hours after exposure, and are characterized by excessive exocrine secretions and autonomic hyperstimulation
- nih.gov
Muscarine toxicity is a peripheral cholinergic toxidrome primarily caused by the ingestion of toxic mushrooms, particularly from the *Inocybe* and *Clitocybe* genera, or from exposure to muscarinic receptor agonists Defining features include pronounced diaphoresis, salivation, lacrimation, miosis, bronchospasm, bronchorrhea, bradycardia, abdominal cramping, nausea, vomiting, and diarrhea
- merckvetmanual.com
Pathophysiologically, the alkaloid muscarine acts as an agonist on postganglionic parasympathetic muscarinic acetylcholine receptors, stimulating the autonomic and peripheral nervous systems without significantly crossing the blood-brain barrier Clinical manifestations typically appear rapidly, often within thirty minutes to two hours after exposure, and are characterized by excessive exocrine secretions and autonomic hyperstimulation
- nih.gov
Defining features include pronounced diaphoresis, salivation, lacrimation, miosis, bronchospasm, bronchorrhea, bradycardia, abdominal cramping, nausea, vomiting, and diarrhea
- nih.gov
Defining features include pronounced diaphoresis, salivation, lacrimation, miosis, bronchospasm, bronchorrhea, bradycardia, abdominal cramping, nausea, vomiting, and diarrhea
- merckmanuals.com
Defining features include pronounced diaphoresis, salivation, lacrimation, miosis, bronchospasm, bronchorrhea, bradycardia, abdominal cramping, nausea, vomiting, and diarrhea
Personalize your experience
Follow Muscarine toxicity and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.